268 related articles for article (PubMed ID: 36081407)
1. Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets.
Al-Mterin MA; Elkord E
Explor Target Antitumor Ther; 2022; 3(4):497-510. PubMed ID: 36081407
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression.
Yin K; Xia X; Rui K; Wang T; Wang S
Front Oncol; 2020; 10():610104. PubMed ID: 33384962
[TBL] [Abstract][Full Text] [Related]
3. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic Analyses of Myeloid-Derived Suppressor Cell Subsets in the Circulation of Colorectal Cancer Patients.
Sasidharan Nair V; Saleh R; Toor SM; Alajez NM; Elkord E
Front Oncol; 2020; 10():1530. PubMed ID: 32984004
[TBL] [Abstract][Full Text] [Related]
5. RNA-Seq Analysis of Colorectal Tumor-Infiltrating Myeloid-Derived Suppressor Cell Subsets Revealed Gene Signatures of Poor Prognosis.
Saleh R; Sasidharan Nair V; Al-Dhaheri M; Khawar M; Abu Nada M; Alajez NM; Elkord E
Front Oncol; 2020; 10():604906. PubMed ID: 33312958
[TBL] [Abstract][Full Text] [Related]
6. Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer.
Yang R; Cai TT; Wu XJ; Liu YN; He J; Zhang XS; Ma G; Li J
Immunology; 2018 Oct; 155(2):263-272. PubMed ID: 29770434
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer.
Sasidharan Nair V; Saleh R; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Alajez NM; Abu Nada M; Elkord E
Clin Epigenetics; 2020 Jan; 12(1):13. PubMed ID: 31941522
[TBL] [Abstract][Full Text] [Related]
8. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
Wang L; Hu D; Xie B; Xie L
Invest New Drugs; 2022 Jun; 40(3):506-518. PubMed ID: 35089465
[TBL] [Abstract][Full Text] [Related]
9. CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients.
Karakasheva TA; Dominguez GA; Hashimoto A; Lin EW; Chiu C; Sasser K; Lee JW; Beatty GL; Gabrilovich DI; Rustgi AK
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563330
[TBL] [Abstract][Full Text] [Related]
10. Granulocytic Myeloid-Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9.
Wang Y; Yin K; Tian J; Xia X; Ma J; Tang X; Xu H; Wang S
Adv Sci (Weinh); 2019 Sep; 6(18):1901278. PubMed ID: 31559140
[TBL] [Abstract][Full Text] [Related]
11. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
[TBL] [Abstract][Full Text] [Related]
12. Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.
OuYang LY; Wu XJ; Ye SB; Zhang RX; Li ZL; Liao W; Pan ZZ; Zheng LM; Zhang XS; Wang Z; Li Q; Ma G; Li J
J Transl Med; 2015 Feb; 13():47. PubMed ID: 25638150
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma.
Sun HL; Zhou X; Xue YF; Wang K; Shen YF; Mao JJ; Guo HF; Miao ZN
World J Gastroenterol; 2012 Jul; 18(25):3303-9. PubMed ID: 22783056
[TBL] [Abstract][Full Text] [Related]
14. The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis.
Bayik D; Lee J; Lathia JD
Exp Suppl; 2022; 113():189-217. PubMed ID: 35165865
[TBL] [Abstract][Full Text] [Related]
15. Targeting Myeloid-Derived Suppressor Cells in Cancer.
Anani W; Shurin MR
Adv Exp Med Biol; 2017; 1036():105-128. PubMed ID: 29275468
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets.
Bizymi N; Bjelica S; Kittang AO; Mojsilovic S; Velegraki M; Pontikoglou C; Roussel M; Ersvær E; Santibañez JF; Lipoldová M; Papadaki HA
Hemasphere; 2019 Feb; 3(1):e168. PubMed ID: 31723807
[TBL] [Abstract][Full Text] [Related]
17. Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.
Srivastava MK; Zhu L; Harris-White M; Huang M; St John M; Lee JM; Salgia R; Cameron RB; Strieter R; Dubinett S; Sharma S
Immunotargets Ther; 2012 Oct; 2012(1):7-12. PubMed ID: 24791250
[TBL] [Abstract][Full Text] [Related]
18. Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.
D'Amico L; Mahajan S; Capietto AH; Yang Z; Zamani A; Ricci B; Bumpass DB; Meyer M; Su X; Wang-Gillam A; Weilbaecher K; Stewart SA; DeNardo DG; Faccio R
J Exp Med; 2016 May; 213(5):827-40. PubMed ID: 27045006
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-Derived Suppressor Cells in Colorectal Cancer.
Sieminska I; Baran J
Front Immunol; 2020; 11():1526. PubMed ID: 32849517
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle Systems Modulating Myeloid-Derived Suppressor Cells for Cancer Immunotherapy.
Wilkerson A; Kim J; Huang AY; Zhang M
Curr Top Med Chem; 2017; 17(16):1843-1857. PubMed ID: 27875974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
